Intraperitoneal chemotherapy for ovarian carcinoma: Results of long-term follow-up Academic Article Article uri icon

Overview

MeSH Major

  • Antigens, Neoplasm
  • Cancer Vaccines
  • Immunotherapy, Adoptive
  • Ovarian Neoplasms

abstract

  • Prolonged survival was observed in selected patients receiving IP platinum-based therapy. It is not possible to determine the contribution of IP therapy to survival in this study. A relationship between size of disease at the initiation of IP therapy and long-term survival was demonstrated.

publication date

  • February 2002

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1200/JCO.20.3.694

PubMed ID

  • 11821450

Additional Document Info

start page

  • 694

end page

  • 8

volume

  • 20

number

  • 3